UPDATE: Lava Therapeutics NV (LVTX) PT Raised to $28 at SVB Leerink, 'SGEN Licensing Deal Provides Validation to LVTX Platform'
Tweet Send to a Friend
(Updated - September 26, 2022 5:19 PM EDT)
SVB Leerink analyst Daina Graybosch raised the price target on Lava ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
SVB Leerink analyst Daina Graybosch raised the price target on Lava ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
